Targeting leucine-rich repeat kinase 2 in Parkinson's disease
10.1517/14728222.2013.842978
Saved in:
Main Authors: | Chan S.L., Angeles D.C., Tan E.-K. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/149121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Molecular biology changes associated with LRRK2 mutations in Parkinson's disease
by: Yi, W.L., et al.
Published: (2014) -
Targeting LRRK2 in Parkinson's disease: an update on recent developments
by: Chan S.L., et al.
Published: (2018) -
Multiple LRRK2 variants modulate risk of Parkinson disease: A Chinese multicenter study
by: Tan, E.-K., et al.
Published: (2014) -
Case-control analysis of leucine-rich repeat kinase 2 protective variants in Alzheimer's disease
by: Ng A.S.L., et al.
Published: (2018) -
LRRK2 mutations are not frequent in Swiss patients with Parkinson's disease
by: Burgunder, J.-M., et al.
Published: (2011)